NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
-1.83%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.21B
AUM Growth
-$221M
(-15%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-11.9%
Top 10 Holdings %
Top 10 Hldgs %
42.91%
Holding
147
New
18
Increased
38
Reduced
57
Closed
11
Top Buys
| 1 |
RH
RH
|
+$11.8M |
| 2 |
Hilton Grand Vacations
HGV
|
+$9.57M |
| 3 |
Gogo Inc
GOGO
|
+$8.54M |
| 4 |
THRD
Third Harmonic Bio
THRD
|
+$8.46M |
| 5 |
Avalo Therapeutics
AVTX
|
+$7.21M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$155M |
| 2 |
Peloton Interactive
PTON
|
+$18.1M |
| 3 |
BlackSky Technology
BKSY
|
+$14.9M |
| 4 |
Pathward Financial
CASH
|
+$14.1M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$13.7M |
Sector Composition
| 1 | Healthcare | 63.52% |
| 2 | Consumer Discretionary | 15.44% |
| 3 | Communication Services | 7.06% |
| 4 | Financials | 4.59% |
| 5 | Industrials | 3.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
BiomX
PHGE
$13.2M
| $1.39M | 0.06% |
2,493,309
+762,709
| +44% | +$424K |
|
102
AYTU BioPharma
AYTU
$21.1M
| $1.3M | 0.05% |
1,086,812
| – | – |
|
103
Context Therapeutics
CNTX
$74.5M
| $1.2M | 0.05% |
1,935,484
| – | – |
|
104
Payoneer
PAYO
$2.34B
| $1.08M | 0.04% |
148,052
-1,390,548
| -90% | -$10.2M |
|
105
Zynex
ZYXI
$46.1M
| $1.07M | 0.04% |
487,778
-2,222
| -0.5% | -$4.89K |
|
106
Strata Skin Sciences
SSKN
$8.38M
| $1.07M | 0.04% |
403,917
| – | – |
|
107
Solid Biosciences
SLDB
$413M
| $1.04M | 0.04% |
+281,368
| New | +$1.04M |
|
108
DarioHealth
DRIO
$17.5M
| $1.04M | 0.04% |
84,615
-37,619
| -31% | -$461K |
|
109
Talphera
TLPH
$20.9M
| $986K | 0.04% |
1,992,519
| – | – |
|
110
Perfect Corp
PERF
$203M
| $894K | 0.04% |
495,041
-4,959
| -1% | -$8.95K |
|
111
SPAR Group
SGRP
$27M
| $872K | 0.03% |
660,688
-1,340
| -0.2% | -$1.77K |
|
112
Herbalife
HLF
$978M
| $863K | 0.03% |
+100,000
| New | +$863K |
|
113
Olaplex Holdings
OLPX
$967M
| $826K | 0.03% |
+650,000
| New | +$826K |
|
114
Acme United Corp
ACU
$160M
| $809K | 0.03% |
+20,427
| New | +$809K |
|
115
Kiora Pharmaceuticals
KPRX
$9.2M
| $635K | 0.03% |
211,110
| – | – |
|
116
Fortress Biotech
FBIO
$112M
| $508K | 0.02% |
325,520
+200,000
| +159% | +$312K |
|
117
Children's Place
PLCE
$151M
| $498K | 0.02% |
57,030
+27,716
| +95% | +$242K |
|
118
Aprea Therapeutics
APRE
$9.03M
| $420K | 0.02% |
205,760
| – | – |
|
119
Evoke Pharma
EVOK
$7.95M
| $407K | 0.02% |
148,153
-41
| -0% | -$113 |
|
|
LADR
120
Ladder Capital
LADR
$1.48B
| $290K | 0.01% |
25,401
-230
| -0.9% | -$2.62K |
|
|
OKUR
121
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$32.5M
| $233K | 0.01% |
54,208
-569
| -1% | -$2.45K |
|
122
Exagen
XGN
$218M
| $220K | 0.01% |
61,186
-930
| -1% | -$3.34K |
|
123
Lexicon Pharmaceuticals
LXRX
$411M
| $212K | 0.01% |
460,850
-6,143,300
| -93% | -$2.83M |
|
124
Lucid Diagnostics
LUCD
$107M
| $141K | 0.01% |
94,541
| – | – |
|
125
Lazydays
GORV
$9.49M
| $60.2K | ﹤0.01% |
6,182
-12,189
| -66% | -$119K |
|